We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company


Leica Biosystems develops and supplies cancer diagnostics devices and solutions in the areas of histology, digital pa... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Leica Biosystems Launches Advanced Staining Solution for Increased Speed, Quality and Diagnostic Productivity

By LabMedica International staff writers
Posted on 02 Jun 2022
Print article
Image: BOND-PRIME Advanced Staining Solution (Photo courtesy of Leica Biosystems)
Image: BOND-PRIME Advanced Staining Solution (Photo courtesy of Leica Biosystems)

Leica Biosystems (Nussloch, Germany) has launched BOND-PRIME, a premium advanced staining solution, to advance diagnostic productivity in the lab. BOND-PRIME is the only system that delivers all elements of universal access, enabling lab technicians to load any slides in any combination, with any reagent, at any time.

The BOND-PRIME staining platform was developed with the lab's needs in mind: in today's fast-paced health care environment, adaptability is essential to ensure that slides are processed in a timely manner. Universal Access on BOND-PRIME seamlessly adapts and optimizes workflow to stain slides as needed, leaving no slide staining position unutilized. BOND-PRIME features 70 open-access reagent positions and can process up to 72 slides seamlessly, helping to eliminate delays and facilitating continuous workflows.

Single or STAT slides may be turned around in as fast as one hour, enabling pathologists to deliver a diagnosis quickly to patients who need answers quickly. In addition to adaptability and speed, BOND-PRIME consistently delivers the crisp, clean stains that are needed for a definitive diagnosis. The instrument's progressive automation works in tandem with Novocastra premium reagents to produce crisp, high-quality staining in an average of 90 minutes.

"With IHC turnaround time shortened to an average of only 90 minutes, and 100% instrument utilization without constant attention, the BOND-PRIME stainer's impact on workflow is truly impressive," said Colin White, Senior Vice President of Advanced Staining and Imaging.

"We have a history of innovation to address customer needs," said Gustavo Perez-Fernandez, President at Leica Biosystems. "From ensuring STAT cases are processed efficiently, to decreasing the number of cases left pending, BOND-PRIME presents a quantifiable benefit to mid-sized and large laboratories."

Related Links:
Leica Biosystems 

Gold Supplier
POC Test Reader
Data Management Software
Silver Supplier
SARS-CoV-2, Influenza A/B Test
Capillary Electrophoresis System

Print article
IIR Middle East



view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more


view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.